Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00183326 · ClinicalTrials.gov registry record · NA

Treating Post Traumatic Stress Disorder in Children Exposed to Domestic Violence

A NA study, sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute).

Completed
Registry status
NA
Development phase
124
Enrollment target

NCT00183326: Completed NA study, sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute).

NCT00183326 is a NA study that has completed, run by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute). The registered enrollment target is 124 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00183326, a NA study, has completed, sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute).

COMPLETED
Registry status
NA
Development phase
124 participants
Enrollment target

Study Summary

This study will determine whether trauma-focused cognitive behavioral therapy (TF-CBT) is more effective than child-centered therapy (CCT) in reducing post traumatic stress disorder (PTSD) in children exposed to domestic violence (DV).

Interventions

  • BEHAVIORAL Trauma-focused cognitive behavioral therapy (TF-CBT)
  • BEHAVIORAL Child-centered supportive therapy (CCT)

Trial Details

FieldValue
Enrollment Target 124 participants
Start Date 2004-05
Est. Completion 2015-07
Phase NA

What the finished NCT00183326 record still lists

NCT00183326 is an interventional study that assigns participants to a tested intervention. The registered 124 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).

The record links to 0 conditions, and to 2 interventions - of which Trauma-focused cognitive behavioral therapy (TF-CBT) is the first listed.

NCT00183326 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00183326 about?

NCT00183326 is a clinical study titled "Treating Post Traumatic Stress Disorder in Children Exposed to Domestic Violence". This study will determine whether trauma-focused cognitive behavioral therapy (TF-CBT) is more effective than child-centered therapy (CCT) in reducing post traumatic stress disorder (PTSD) in children exposed to domestic violence (DV).

What is the current status of trial NCT00183326?

This trial is currently completed. It is a NA study. The enrollment target is 124 participants. The study started on 2004-05. Estimated completion is 2015-07.

What interventions are being tested in trial NCT00183326?

The interventions under investigation include: Trauma-focused cognitive behavioral therapy (TF-CBT) (BEHAVIORAL), Child-centered supportive therapy (CCT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT00183326?

This trial is sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute), which has 34 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00183326's enrollment target sits among peer trials

124 758th of 2000 higher than 1,239 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02523014 · 124 participants · Phase 2

    Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

  • NCT02670707 · 124 participants · Phase 3

    Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)

  • NCT02830724 · 124 participants · Phase 1

    Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers

  • NCT04748809 · 124 participants · NA

    Effect of Anti-inflammatory Diet in Rheumatoid Arthritis

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00183326, the US trial registry maintained by the National Library of Medicine. NCT00183326 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.